A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot study

OBJECTIVE: We aimed at comparing clinical/immunological outcomes in human immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and conventional efavirenz (EFV) therapy. METHODS: This study was a 24-week prospective randomized controlled trial. Eligible patients were HIV...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pharmgenomics Pers Med
Autores principales: Damronglerd, Pansachee, Sukasem, Chonlaphat, Thipmontree, Wilawan, Puangpetch, Apichaya, Kiertiburanakul, Sasisopin
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4638311/
https://ncbi.nlm.nih.gov/pubmed/26622191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S86446
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares